Rating
Buy
Price target
$200
Previous
Implied upside
+13%

Barclays analyst Tom O’Malley reiterated on September 22, 2025, an ‘Overweight’ rating and $200 price target on Nvidia.

“Our Take

Just a few weeks ago, the latest in AI hype was around AVGO’s $10B deal with OpenAI (see here for our thoughts post-earnings).

Since this deal, the conversation has shifted to “is custom ASIC the future?”, especially with the slightly lower Compute number from NVDA at earnings.

Today’s announcement shows that we are in a compute bonanza and while the custom silicon announcement came first, general purpose silicon will run the majority of OpenAI (private, not covered) workloads at least through the end of this decade.

Based on commentary from NVDA’s 2Q26 earnings (full thoughts here), 1GW is the equivalent of ~$35B+ revenue to NVDA, which translates to ~$350B+ from this OpenAI partnership to deploy 10GW of NVDA systems.

NVDA is 3.5x ($35B vs. $10B) the size of the ASIC program in the 2H of next year at OpenAI.

It’s clear that both custom and general purpose compute are in max demand in this environment, but we don’t think NVDA is getting enough credit as this deal is entirely incremental and could add $35B to Street numbers (both compute and networking).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.